• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

房颤对重度二尖瓣反流患者经导管缘对缘修复术的影响。

Impact of Atrial Fibrillation in Patients With Severe Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair.

作者信息

Mannina Carlo, Sharma Akarsh, Prakash Yash, Carbone Andreina, Bossone Eduardo, Tuttolomondo Antonino, Argulian Edgar, Khera Sahil, Melarcode-Krishnamoorthy Parasuram, Dangas George, Halperin Jonathan, Tang Gilbert H L, Sharma Samin, Kini Annapoorna, Stone Gregg W, Lerakis Stamatios

机构信息

Division of Cardiology Mount Sinai Morningside, Icahn School of Medicine at Mount Sinai New York NY USA.

Department of Internal Medicine University of Palermo Palermo Italy.

出版信息

J Am Heart Assoc. 2025 Aug 5;14(15):e042016. doi: 10.1161/JAHA.125.042016. Epub 2025 Jul 17.

DOI:10.1161/JAHA.125.042016
PMID:40673540
Abstract

BACKGROUND

Atrial fibrillation (AF) and mitral regurgitation (MR) are closely linked, and one may worsen the other. We investigated the impact of baseline AF in patients with MR undergoing transcatheter edge-to-edge repair.

METHODS

One-hundred-fifty-six consecutive patients with symptomatic heart failure (HF) undergoing mitral valve transcatheter edge-to-edge repair for severe MR were studied. The primary end point was the composite outcome of death or HF hospitalization. Transthoracic echocardiograms were performed at baseline and follow-up.

RESULTS

Mean age was 80.8±8.8 years and 82 (52.6%) patients were female. MR cause was primary in 69 (44.2%) and secondary in 87 (55.8%) patients. AF or atrial flutter was present in 59 (37.8%) patients at baseline. Mitral valve transcatheter edge-to-edge repair was successful (≤2+ MR) in 58 (98.3%) and 94 (96.9%) patients with and without AF respectively (=0.59). During median 12.5 months follow-up, the primary end point occurred in 64 patients (2-year Kaplan-Meier estimated rate 41.0%), including death in 16 patients (10.3%) and HF hospitalization in 57 patients (36.5%). Baseline AF remained a significant independent predictor of death or HF hospitalization (adjusted hazard ratio, 2.03 [95% CI, 1.12-3.69], =0.02). Left ventricular end-diastolic volume, left atrial volume, and right ventricular systolic pressure decreased during follow-up among patients in sinus rhythm but not among those in AF. AF was associated with an increased risk of severe MR recurrence (18.6% versus 8.2%, =0.05).

CONCLUSIONS

In patients with HF and severe MR treated with Mitral valve transcatheter edge-to-edge repair, baseline AF was associated with impaired right and left heart remodeling, more frequent MR recurrence, and more than doubling of the 2-year risk of death or HF hospitalization.

摘要

背景

心房颤动(AF)与二尖瓣反流(MR)密切相关,二者可能相互恶化。我们研究了基线房颤对接受经导管缘对缘修复术的二尖瓣反流患者的影响。

方法

对156例因严重二尖瓣反流接受二尖瓣经导管缘对缘修复术的有症状心力衰竭(HF)患者进行了研究。主要终点是死亡或心力衰竭住院的复合结局。在基线和随访时进行经胸超声心动图检查。

结果

平均年龄为80.8±8.8岁,82例(52.6%)患者为女性。69例(44.2%)患者的二尖瓣反流病因是原发性的,87例(55.8%)患者是继发性的。59例(37.8%)患者在基线时存在房颤或房扑。二尖瓣经导管缘对缘修复术在有房颤和无房颤的患者中分别有58例(98.3%)和94例(96.9%)成功(≤2+二尖瓣反流)(P=0.59)。在中位12.5个月的随访期间,64例患者出现了主要终点(2年Kaplan-Meier估计发生率为41.0%),包括16例患者死亡(10.3%)和57例患者心力衰竭住院(36.5%)。基线房颤仍然是死亡或心力衰竭住院的显著独立预测因素(调整后的风险比为2.03[95%CI,1.12-3.69],P=0.02)。在随访期间,窦性心律患者的左心室舒张末期容积、左心房容积和右心室收缩压下降,但房颤患者未下降。房颤与严重二尖瓣反流复发风险增加相关(18.6%对8.2%,P=0.05)。

结论

在接受二尖瓣经导管缘对缘修复术治疗的心力衰竭和严重二尖瓣反流患者中,基线房颤与左右心重构受损、二尖瓣反流复发更频繁以及2年死亡或心力衰竭住院风险增加一倍以上相关。

相似文献

1
Impact of Atrial Fibrillation in Patients With Severe Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair.房颤对重度二尖瓣反流患者经导管缘对缘修复术的影响。
J Am Heart Assoc. 2025 Aug 5;14(15):e042016. doi: 10.1161/JAHA.125.042016. Epub 2025 Jul 17.
2
Clinical Outcomes of Mitral Regurgitation Severity and Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation.心房功能性二尖瓣反流中二尖瓣反流严重程度及经导管缘对缘修复的临床结果
Catheter Cardiovasc Interv. 2025 Jul;106(1):494-503. doi: 10.1002/ccd.31567. Epub 2025 May 4.
3
Impact of Natriuretic Peptide and Prior Hospitalization in Patients With Severe Mitral Regurgitation: COAPT Trial.利钠肽及既往住院史对重度二尖瓣反流患者的影响:COAPT试验
Circ Cardiovasc Interv. 2025 Jul;18(7):e015192. doi: 10.1161/CIRCINTERVENTIONS.125.015192. Epub 2025 May 13.
4
Impact of heart failure severity on the mortality benefit of mitral transcatheter edge-to-edge valve repair.心力衰竭严重程度对二尖瓣经导管缘对缘瓣膜修复术死亡率获益的影响。
Clin Res Cardiol. 2024 Jul 24. doi: 10.1007/s00392-024-02490-7.
5
Plasma volume status predicting clinical outcomes in patients undergoing transcatheter edge-to-edge mitral valve repair.预测经导管二尖瓣缘对缘修复术患者临床结局的血浆容量状态
ESC Heart Fail. 2025 Apr 17. doi: 10.1002/ehf2.15295.
6
Prognostic value of baseline RV dysfunction using TAPSE and TAPSE to PASP ratio in patients undergoing mitra-clip: a systematic review and meta-analysis.使用三尖瓣环平面收缩期位移(TAPSE)及TAPSE与肺动脉收缩压(PASP)比值评估接受二尖瓣夹合术患者基线右心室功能障碍的预后价值:一项系统评价和荟萃分析
Int J Cardiovasc Imaging. 2025 May;41(5):827-846. doi: 10.1007/s10554-025-03354-5. Epub 2025 Mar 22.
7
Validation of the COAPT risk score in Polish patients undergoing transcatheter edge-to-edge repair of severe, functional mitral regurgitation: a multicenter, observational study.COAPT风险评分在接受经导管缘对缘修复严重功能性二尖瓣反流的波兰患者中的验证:一项多中心观察性研究。
Cardiol J. 2025;32(3):258-269. doi: 10.5603/cj.100877.
8
Findings from transoesophageal echocardiographic follow-up after mitral transcatheter edge-to-edge repair.经食管超声心动图随访二尖瓣经导管缘对缘修复术后结果。
EuroIntervention. 2024 Oct 21;20(20):e1298-e1308. doi: 10.4244/EIJ-D-24-00297.
9
Transcatheter Approaches to Atrial Functional Mitral Regurgitation: How Far Have We Come?经导管治疗心房功能性二尖瓣反流:我们进展到了什么程度?
Catheter Cardiovasc Interv. 2025 Jul;106(1):28-40. doi: 10.1002/ccd.31368. Epub 2024 Dec 26.
10
2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation.经导管二尖瓣置换术治疗重度症状性二尖瓣反流患者的 2 年结果。
J Am Coll Cardiol. 2021 Nov 9;78(19):1847-1859. doi: 10.1016/j.jacc.2021.08.060.